Interpreting the clinical significance of capacity scores for informed consent in alzheimer disease clinical trials

Jason Karlawish, Scott Y.H. Kim, David Knopman, Christopher H. Van Dyck, Bryan D. James, M. Bioethics, Daniel Marson

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Interpreting the clinical significance of capacity scores for informed consent in alzheimer disease clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences